AMDL Inc. (ADL) announced that it's wholly owned subsidiary, Jade Pharmaceutical Inc., has signed a letter of intent with China-based Sichuan ZhiTong Pharmaceutical Ltd.
Under the terms of the letter of intent, Jade Pharmaceutical and Sichuan ZhiTong Pharmaceutical would consolidate sales forces and enter into a distribution agreement where the Sichuan ZhiTong would distribute additional AMDL pharmaceutical products including GoodNak, Levofloxicin and Ondansetron.
The company noted that Sichuan ZhiTong sells and distributes traditional Chinese medicines, health foods, medical equipment, and generic pharmaceutical products.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.